Trials / Completed
CompletedNCT04377321
Colchicine Has Anti-diabetic Effect
Colchicine Has Anti-diabetic Effect and May be an Option for Type 2 Diabetes Management
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Ministry of Health and Population, Egypt · Other Government
- Sex
- All
- Age
- 35 Years – 55 Years
- Healthy volunteers
- —
Summary
Colchicine has antidiabetic effect and may be an option for type 2 diabetes management
Detailed description
Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with 30 females and 20 males after written consent from all patients. The ages of all patients were between 35 and 55 years. The aim of this study was to evaluate colchicine effect on A1C of newly diagnosed type2 diabetes compared to the metformin and control group on diet only. The first group patients received colchicine 0.5twice daily for 6 months, the second group received metformin 1gm twice daily, the third group patients were on diet only. During the period of treatment, the investigators followed the patients if there were side effects of the drugs used. No side effects were monitored during the period of treatment except for gastric upset in some patients using metformin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colchicine Tablets | colchicine tabletes for 6 months |
Timeline
- Start date
- 2019-10-10
- Primary completion
- 2020-05-01
- Completion
- 2020-05-02
- First posted
- 2020-05-06
- Last updated
- 2020-05-06
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04377321. Inclusion in this directory is not an endorsement.